Clinical Trials Browser

Phase 2 × Lymphoma, Large B-Cell, Diffuse × BEBT-908 × Clear all

NCT06074107 2023-10-11

Study of BEBT-908 in the Relapsed or Refractory Diffuse Large B-cell Lymphoma Subjects

Phase 2 Unknown

Recurrence, Lymphoma, Large B-Cell, Diffuse